Company intelligence / Profile preview

Zedsen

London, England, United Kingdomzedsen.com ↗

Ownership: Private
Employees: ~18
Development stage: Preclinical

Overview

Zedsen has developed a non-invasive, portable medical device for early and accurate breast cancer screening. As of July 2023, the company was entering its first clinical study and had not yet reported clinical results. The technology aims to revolutionize the diagnostic pathway in oncology by providing accessible and accurate detection.

Therapeutic areas: Oncology
Modalities: DeviceBiosensor
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Zedsen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zedsen.

Explore the full profile